CARSGEN-B (02171) announces its interim results with a net loss of 75.48 million yuan, a year-on-year decrease of 78.53%.

date
14/08/2025
avatar
GMT Eight
Kozi Pharmaceutical-B (02171) announced its mid-term performance for 2025, with a profit of 50.961 million RMB, a year-on-year increase...
CARSGEN-B (02171) announced its mid-term performance for 2025, with a profit of 50.961 million yuan, an increase of 703.8% year-on-year; a gross profit of 29.369 million yuan, an increase of approximately 17.16 times year-on-year; a net loss of 75.483 million yuan, which narrowed by 78.53% year-on-year; and a loss per share of 0.14 yuan. The announcement stated that the decrease in losses was mainly due to a reduction in research and development expenses, a reduction in administrative expenses, an increase in net foreign exchange gains, and an increase in gross profit.